Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 6Gynecologic 3Sarcoma 2NET 2Head & Neck 2Gastrointestinal 2Endocrine 2CNS 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Dermatologic 1Breast 1

Conditions

Sarcoma 26Gliosarcoma 22Glioblastoma 21Glioma 16Ependymoma 15Astrocytoma 12Osteosarcoma 11Oligodendroglioma 11Central Nervous System Neoplasms 10Rhabdomyosarcoma 9Medulloblastoma 9Sarcoma, Ewing 7Neuroblastoma 7Glioma, Subependymal 7Brain Neoplasms 7Rhabdoid Tumor 6Neuroectodermal Tumors, Primitive, Peripheral 6Neuroectodermal Tumors, Primitive 6Neoplasm Metastasis 6Lymphoma, Non-Hodgkin 6Lung Neoplasms 6Histiocytosis, Langerhans-Cell 6Carcinosarcoma 6Wilms Tumor 5Liposarcoma 5Hepatoblastoma 5Carcinoma, Transitional Cell 5Sarcoma, Kaposi 4Ovarian Neoplasms 4Meningioma 4

Interventions

Filgrastim 8Carboplatin 8Peripheral Blood Stem Cell Transplantation 6Etoposide 5Thiotepa 4Melphalan 4Cyclophosphamide 4Busulfan 4Temozolomide 3Radiotherapy 3Polymerase Chain Reaction 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3etoposide phosphate 2aflibercept 2Topotecan 2Therapeutics 2Psychiatric Rehabilitation 2Magnetic Resonance Spectroscopy 2Itraconazole 2Flow Cytometry 2Carmustine 2Bone Marrow Transplantation 2Blood Specimen Collection 2Amplified Fragment Length Polymorphism Analysis 2Amifostine 2trioctyl phosphine oxide 1tremelimumab 1trastuzumab deruxtecan 1thymoglobulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Testicular Neoplasms × Magnetic Resonance Spectroscopy × Sarcoma × Clear all
NCT07118176 2025-08-12

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Jonsson Comprehensive Cancer Center

Phase 1 Recruiting
30 enrolled
BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETSarcomaThoracic

Adrenal Gland Neoplasms, Anus Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Colorectal Neoplasms, Carcinoma, Medullary, Cholangiocarcinoma, Neuroendocrine Tumors, Solitary Fibrous Tumors

NCT00123773 2016-02-26

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

AHS Cancer Control Alberta

Phase 2 Completed
1,075 enrolled
GenitourinaryGynecologicPlasma cellSarcoma

Kidney Neoplasms, Multiple Myeloma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡